GOOGL
40
-5
BAC
53
3
JWN
48
6
MAT
46
12
VZ
50
3
DRI
53
5
INTU
56
-4
PFE
23
7
TDC
80
4
PFG
45
3
FDX
43
3
BSX
67
-3
ZION
65
2
WU
32
2
NVDA
56
-4
CVX
47
3
EL
25
4
BMY
60
2
URBN
56
14
PSX
47
2
GOOGL
40
-5
BAC
53
3
JWN
48
6
MAT
46
12
VZ
50
3
DRI
53
5
INTU
56
-4
PFE
23
7
TDC
80
4
PFG
45
3
FDX
43
3
BSX
67
-3
ZION
65
2
WU
32
2
NVDA
56
-4
CVX
47
3
EL
25
4
BMY
60
2
URBN
56
14
PSX
47
2
Financhill
Back

InspireMD Vs. Perspective Therapeutics Industry Stock Comparison

Buy
61

NSPR
InspireMD

Last Price:
2.62
Seasonality Move:
8.64%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
61
InspireMD (NSPR) is a Buy

Is InspireMD a Buy, Sell or Hold?

  • The current InspireMD [NSPR] share price is $2.65. The Score for NSPR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • NSPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NSPR Stock Price Chart

What is InspireMD's stock price today?

  • The InspireMD share price today is $2.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NSPR is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NSPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 58.51 Buy
Chaikin Money Flow: 9284 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.57) Buy
Bollinger Bands (100): (2.45 - 2.87) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

NSPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.58 Buy
20-day SMA: 2.49 Buy
50-day SMA: 2.57 Buy
200-day SMA: 2.54 Buy
8-day EMA: 2.57 Buy
20-day EMA: 2.53 Buy
50-day EMA: 2.56 Buy
200-day EMA: 2.59 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

InspireMD Earnings Growth & NSPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

InspireMD Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):